Medtronic acquires SPR Therapeutics for $650 million
Medtronic plc (NYSE: MDT) announced it has completed the acquisition of SPR Therapeutics, Inc., a privately held medical technology company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
